Clinical trial
A Randomised, Double-blind, Placebo-controlled Exploratory Study to Explore the Efficacy and Safety of PQ Grass 27600 SU in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen Exposure
NCT04687059 is registered in ClinicalTrials.gov with Allergy Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Double-blind, Placebo-controlled Exploratory Study to Explore the Efficacy and Safety of PQ Grass 27600 SU in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen Exposure
- Lead sponsor
- Allergy Therapeutics
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 19, 2020
- Completion date
- October 28, 2021
- Enrollment
- 119 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.